![]() |
|||||||
|
Fusion Protein:FGFR3-AMBRA1 |
Fusion Gene and Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: FGFR3-AMBRA1 | FusionPDB ID: 30300 | FusionGDB2.0 ID: 30300 | Hgene | Tgene | Gene symbol | FGFR3 | AMBRA1 | Gene ID | 2261 | 55626 |
Gene name | fibroblast growth factor receptor 3 | autophagy and beclin 1 regulator 1 | |
Synonyms | ACH|CD333|CEK2|HSFGFR3EX|JTK4 | DCAF3|WDR94 | |
Cytomap | 4p16.3 | 11p11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | fibroblast growth factor receptor 3FGFR-3fibroblast growth factor receptor 3 variant 4fibroblast growth factor receptor 3-Shydroxyaryl-protein kinasetyrosine kinase JTK4 | activating molecule in BECN1-regulated autophagy protein 1DDB1 and CUL4 associated factor 3WD repeat domain 94activating molecule in beclin-1-regulated autophagyautophagy/beclin-1 regulator 1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P22607 Main function of 5'-partner protein: FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferation. Required for normal development of the inner ear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Plays a role in the regulation of vitamin D metabolism. Mutations that lead to constitutive kinase activation or impair normal FGFR3 maturation, internalization and degradation lead to aberrant signaling. Over-expressed or constitutively activated FGFR3 promotes activation of PTPN11/SHP2, STAT1, STAT5A and STAT5B. Secreted isoform 3 retains its capacity to bind FGF1 and FGF2 and hence may interfere with FGF signaling. {ECO:0000269|PubMed:10611230, ECO:0000269|PubMed:11294897, ECO:0000269|PubMed:11703096, ECO:0000269|PubMed:14534538, ECO:0000269|PubMed:16410555, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17145761, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17509076, ECO:0000269|PubMed:17561467, ECO:0000269|PubMed:19088846, ECO:0000269|PubMed:19286672, ECO:0000269|PubMed:8663044}. | Q9C0C7 Main function of 5'-partner protein: FUNCTION: Regulates autophagy and development of the nervous system. Involved in autophagy in controlling protein turnover during neuronal development, and in regulating normal cell survival and proliferation (By similarity). {ECO:0000250}. | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000260795, ENST00000340107, ENST00000352904, ENST00000412135, ENST00000440486, ENST00000481110, ENST00000474521, | ENST00000529963, ENST00000298834, ENST00000314845, ENST00000426438, ENST00000458649, ENST00000528950, ENST00000533727, ENST00000534300, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 10 X 22 X 14=3080 | 17 X 12 X 8=1632 |
# samples | 33 | 19 | |
** MAII score | log2(33/3080*10)=-3.22239242133645 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(19/1632*10)=-3.10256973364055 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Fusion gene context | PubMed: FGFR3 [Title/Abstract] AND AMBRA1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Fusion neoantigen context | PubMed: FGFR3 [Title/Abstract] AND AMBRA1 [Title/Abstract] AND neoantigen [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | FGFR3(1808661)-AMBRA1(46439602), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | FGFR3-AMBRA1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR3-AMBRA1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR3-AMBRA1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR3-AMBRA1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR3-AMBRA1 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. FGFR3-AMBRA1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. FGFR3-AMBRA1 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. FGFR3-AMBRA1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FGFR3 | GO:0008543 | fibroblast growth factor receptor signaling pathway | 8663044 |
Hgene | FGFR3 | GO:0018108 | peptidyl-tyrosine phosphorylation | 11294897 |
Hgene | FGFR3 | GO:0046777 | protein autophosphorylation | 11294897 |
Tgene | AMBRA1 | GO:0000423 | mitophagy | 21753002 |
Tgene | AMBRA1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 21753002 |
Tgene | AMBRA1 | GO:0098780 | response to mitochondrial depolarisation | 21753002 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr4:1808661/chr11:46439602) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Amino Acid Sequences |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000440486 | FGFR3 | chr4 | 1808661 | + | ENST00000298834 | AMBRA1 | chr11 | 46439602 | - | 4487 | 2530 | 223 | 3450 | 1075 |
ENST00000440486 | FGFR3 | chr4 | 1808661 | + | ENST00000426438 | AMBRA1 | chr11 | 46439602 | - | 4487 | 2530 | 223 | 3450 | 1075 |
ENST00000440486 | FGFR3 | chr4 | 1808661 | + | ENST00000314845 | AMBRA1 | chr11 | 46439602 | - | 4487 | 2530 | 223 | 3450 | 1075 |
ENST00000440486 | FGFR3 | chr4 | 1808661 | + | ENST00000533727 | AMBRA1 | chr11 | 46439602 | - | 4487 | 2530 | 223 | 3450 | 1075 |
ENST00000440486 | FGFR3 | chr4 | 1808661 | + | ENST00000534300 | AMBRA1 | chr11 | 46439602 | - | 4487 | 2530 | 223 | 3450 | 1075 |
ENST00000440486 | FGFR3 | chr4 | 1808661 | + | ENST00000458649 | AMBRA1 | chr11 | 46439602 | - | 4486 | 2530 | 223 | 3450 | 1075 |
ENST00000440486 | FGFR3 | chr4 | 1808661 | + | ENST00000528950 | AMBRA1 | chr11 | 46439602 | - | 3451 | 2530 | 223 | 3450 | 1076 |
ENST00000412135 | FGFR3 | chr4 | 1808661 | + | ENST00000298834 | AMBRA1 | chr11 | 46439602 | - | 4151 | 2194 | 223 | 3114 | 963 |
ENST00000412135 | FGFR3 | chr4 | 1808661 | + | ENST00000426438 | AMBRA1 | chr11 | 46439602 | - | 4151 | 2194 | 223 | 3114 | 963 |
ENST00000412135 | FGFR3 | chr4 | 1808661 | + | ENST00000314845 | AMBRA1 | chr11 | 46439602 | - | 4151 | 2194 | 223 | 3114 | 963 |
ENST00000412135 | FGFR3 | chr4 | 1808661 | + | ENST00000533727 | AMBRA1 | chr11 | 46439602 | - | 4151 | 2194 | 223 | 3114 | 963 |
ENST00000412135 | FGFR3 | chr4 | 1808661 | + | ENST00000534300 | AMBRA1 | chr11 | 46439602 | - | 4151 | 2194 | 223 | 3114 | 963 |
ENST00000412135 | FGFR3 | chr4 | 1808661 | + | ENST00000458649 | AMBRA1 | chr11 | 46439602 | - | 4150 | 2194 | 223 | 3114 | 963 |
ENST00000412135 | FGFR3 | chr4 | 1808661 | + | ENST00000528950 | AMBRA1 | chr11 | 46439602 | - | 3115 | 2194 | 223 | 3114 | 964 |
ENST00000340107 | FGFR3 | chr4 | 1808661 | + | ENST00000298834 | AMBRA1 | chr11 | 46439602 | - | 4493 | 2536 | 223 | 3456 | 1077 |
ENST00000340107 | FGFR3 | chr4 | 1808661 | + | ENST00000426438 | AMBRA1 | chr11 | 46439602 | - | 4493 | 2536 | 223 | 3456 | 1077 |
ENST00000340107 | FGFR3 | chr4 | 1808661 | + | ENST00000314845 | AMBRA1 | chr11 | 46439602 | - | 4493 | 2536 | 223 | 3456 | 1077 |
ENST00000340107 | FGFR3 | chr4 | 1808661 | + | ENST00000533727 | AMBRA1 | chr11 | 46439602 | - | 4493 | 2536 | 223 | 3456 | 1077 |
ENST00000340107 | FGFR3 | chr4 | 1808661 | + | ENST00000534300 | AMBRA1 | chr11 | 46439602 | - | 4493 | 2536 | 223 | 3456 | 1077 |
ENST00000340107 | FGFR3 | chr4 | 1808661 | + | ENST00000458649 | AMBRA1 | chr11 | 46439602 | - | 4492 | 2536 | 223 | 3456 | 1077 |
ENST00000340107 | FGFR3 | chr4 | 1808661 | + | ENST00000528950 | AMBRA1 | chr11 | 46439602 | - | 3457 | 2536 | 223 | 3456 | 1078 |
ENST00000260795 | FGFR3 | chr4 | 1808661 | + | ENST00000298834 | AMBRA1 | chr11 | 46439602 | - | 4333 | 2376 | 69 | 3296 | 1075 |
ENST00000260795 | FGFR3 | chr4 | 1808661 | + | ENST00000426438 | AMBRA1 | chr11 | 46439602 | - | 4333 | 2376 | 69 | 3296 | 1075 |
ENST00000260795 | FGFR3 | chr4 | 1808661 | + | ENST00000314845 | AMBRA1 | chr11 | 46439602 | - | 4333 | 2376 | 69 | 3296 | 1075 |
ENST00000260795 | FGFR3 | chr4 | 1808661 | + | ENST00000533727 | AMBRA1 | chr11 | 46439602 | - | 4333 | 2376 | 69 | 3296 | 1075 |
ENST00000260795 | FGFR3 | chr4 | 1808661 | + | ENST00000534300 | AMBRA1 | chr11 | 46439602 | - | 4333 | 2376 | 69 | 3296 | 1075 |
ENST00000260795 | FGFR3 | chr4 | 1808661 | + | ENST00000458649 | AMBRA1 | chr11 | 46439602 | - | 4332 | 2376 | 69 | 3296 | 1075 |
ENST00000260795 | FGFR3 | chr4 | 1808661 | + | ENST00000528950 | AMBRA1 | chr11 | 46439602 | - | 3297 | 2376 | 69 | 3296 | 1075 |
ENST00000352904 | FGFR3 | chr4 | 1808661 | + | ENST00000298834 | AMBRA1 | chr11 | 46439602 | - | 3934 | 1977 | 6 | 2897 | 963 |
ENST00000352904 | FGFR3 | chr4 | 1808661 | + | ENST00000426438 | AMBRA1 | chr11 | 46439602 | - | 3934 | 1977 | 6 | 2897 | 963 |
ENST00000352904 | FGFR3 | chr4 | 1808661 | + | ENST00000314845 | AMBRA1 | chr11 | 46439602 | - | 3934 | 1977 | 6 | 2897 | 963 |
ENST00000352904 | FGFR3 | chr4 | 1808661 | + | ENST00000533727 | AMBRA1 | chr11 | 46439602 | - | 3934 | 1977 | 6 | 2897 | 963 |
ENST00000352904 | FGFR3 | chr4 | 1808661 | + | ENST00000534300 | AMBRA1 | chr11 | 46439602 | - | 3934 | 1977 | 6 | 2897 | 963 |
ENST00000352904 | FGFR3 | chr4 | 1808661 | + | ENST00000458649 | AMBRA1 | chr11 | 46439602 | - | 3933 | 1977 | 6 | 2897 | 963 |
ENST00000352904 | FGFR3 | chr4 | 1808661 | + | ENST00000528950 | AMBRA1 | chr11 | 46439602 | - | 2898 | 1977 | 6 | 2897 | 963 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000440486 | ENST00000298834 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002724015 | 0.997276 |
ENST00000440486 | ENST00000426438 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002724015 | 0.997276 |
ENST00000440486 | ENST00000314845 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002724015 | 0.997276 |
ENST00000440486 | ENST00000533727 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002724015 | 0.997276 |
ENST00000440486 | ENST00000534300 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002724015 | 0.997276 |
ENST00000440486 | ENST00000458649 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002715871 | 0.9972842 |
ENST00000440486 | ENST00000528950 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.004706109 | 0.9952939 |
ENST00000412135 | ENST00000298834 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002145476 | 0.99785453 |
ENST00000412135 | ENST00000426438 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002145476 | 0.99785453 |
ENST00000412135 | ENST00000314845 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002145476 | 0.99785453 |
ENST00000412135 | ENST00000533727 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002145476 | 0.99785453 |
ENST00000412135 | ENST00000534300 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002145476 | 0.99785453 |
ENST00000412135 | ENST00000458649 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002138537 | 0.99786144 |
ENST00000412135 | ENST00000528950 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.003931421 | 0.9960686 |
ENST00000340107 | ENST00000298834 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.003208912 | 0.99679106 |
ENST00000340107 | ENST00000426438 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.003208912 | 0.99679106 |
ENST00000340107 | ENST00000314845 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.003208912 | 0.99679106 |
ENST00000340107 | ENST00000533727 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.003208912 | 0.99679106 |
ENST00000340107 | ENST00000534300 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.003208912 | 0.99679106 |
ENST00000340107 | ENST00000458649 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.003201071 | 0.9967989 |
ENST00000340107 | ENST00000528950 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.00545479 | 0.9945452 |
ENST00000260795 | ENST00000298834 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002315655 | 0.99768436 |
ENST00000260795 | ENST00000426438 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002315655 | 0.99768436 |
ENST00000260795 | ENST00000314845 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002315655 | 0.99768436 |
ENST00000260795 | ENST00000533727 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002315655 | 0.99768436 |
ENST00000260795 | ENST00000534300 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002315655 | 0.99768436 |
ENST00000260795 | ENST00000458649 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002307882 | 0.9976921 |
ENST00000260795 | ENST00000528950 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.004174669 | 0.9958254 |
ENST00000352904 | ENST00000298834 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002051718 | 0.99794835 |
ENST00000352904 | ENST00000426438 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002051718 | 0.99794835 |
ENST00000352904 | ENST00000314845 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002051718 | 0.99794835 |
ENST00000352904 | ENST00000533727 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002051718 | 0.99794835 |
ENST00000352904 | ENST00000534300 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002051718 | 0.99794835 |
ENST00000352904 | ENST00000458649 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.002044173 | 0.9979558 |
ENST00000352904 | ENST00000528950 | FGFR3 | chr4 | 1808661 | + | AMBRA1 | chr11 | 46439602 | - | 0.003967302 | 0.99603266 |
![]() |
Get the fusion protein sequences from here. |
Fusion protein sequence information is available in the fasta format. >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP |
Top |
Fusion Protein Breakpoint Sequences for FGFR3-AMBRA1 |
![]() |
Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Length(fusion protein) | BP in fusion protein | Peptide |
FGFR3 | chr4 | 1808661 | AMBRA1 | chr11 | 46439602 | 1977 | 654 | QLVEDLDRVLTVTSTDRVFNVLYPMP |
FGFR3 | chr4 | 1808661 | AMBRA1 | chr11 | 46439602 | 2194 | 654 | QLVEDLDRVLTVTSTDRVFNVLYPMP |
FGFR3 | chr4 | 1808661 | AMBRA1 | chr11 | 46439602 | 2376 | 766 | QLVEDLDRVLTVTSTDRVFNVLYPMP |
FGFR3 | chr4 | 1808661 | AMBRA1 | chr11 | 46439602 | 2530 | 766 | QLVEDLDRVLTVTSTDRVFNVLYPMP |
FGFR3 | chr4 | 1808661 | AMBRA1 | chr11 | 46439602 | 2536 | 768 | QLVEDLDRVLTVTSTDRVFNVLYPMP |
Top |
Potential FusionNeoAntigen Information of FGFR3-AMBRA1 in HLA I |
![]() |
FGFR3-AMBRA1_1808661_46439602.msa |
![]() * We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5) |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA I | FusionNeoAntigen peptide | Binding score | Immunogenic score | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-A74:09 | RVLTVTSTDR | 0.9861 | 0.5933 | 7 | 17 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-A74:03 | RVLTVTSTDR | 0.9861 | 0.5933 | 7 | 17 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-A74:11 | RVLTVTSTDR | 0.9861 | 0.5933 | 7 | 17 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-A31:06 | RVLTVTSTDR | 0.9817 | 0.5297 | 7 | 17 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-A03:12 | RVLTVTSTDR | 0.9736 | 0.5456 | 7 | 17 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-A31:02 | RVLTVTSTDR | 0.9603 | 0.603 | 7 | 17 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C15:06 | TSTDRVFNV | 0.9992 | 0.8566 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C12:04 | TSTDRVFNV | 0.9275 | 0.9895 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C06:03 | TSTDRVFNV | 0.9054 | 0.9814 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C02:06 | TSTDRVFNV | 0.6068 | 0.9464 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-A31:01 | RVLTVTSTDR | 0.9881 | 0.5666 | 7 | 17 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C15:02 | TSTDRVFNV | 0.9995 | 0.8239 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C15:05 | TSTDRVFNV | 0.9995 | 0.8568 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-A69:01 | TSTDRVFNV | 0.9924 | 0.7424 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C16:02 | TSTDRVFNV | 0.9824 | 0.9904 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C16:04 | TSTDRVFNV | 0.9379 | 0.9427 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C03:02 | TVTSTDRVF | 0.9312 | 0.958 | 10 | 19 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-C12:03 | TSTDRVFNV | 0.713 | 0.9476 | 12 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | HLA-A74:01 | RVLTVTSTDR | 0.9861 | 0.5933 | 7 | 17 |
Top |
Potential FusionNeoAntigen Information of FGFR3-AMBRA1 in HLA II |
![]() |
FGFR3-AMBRA1_1808661_46439602.msa |
![]() * We used NetMHCIIpan v4.1 (%rank<0.5). |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA II | FusionNeoAntigen peptide | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | DRB1-1410 | DRVLTVTSTDRVFNV | 6 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | DRB1-1410 | LDRVLTVTSTDRVFN | 5 | 20 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | DRB4-0101 | DRVLTVTSTDRVFNV | 6 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | DRB4-0103 | DRVLTVTSTDRVFNV | 6 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | DRB4-0104 | DRVLTVTSTDRVFNV | 6 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | DRB4-0106 | DRVLTVTSTDRVFNV | 6 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | DRB4-0107 | DRVLTVTSTDRVFNV | 6 | 21 |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 | DRB4-0108 | DRVLTVTSTDRVFNV | 6 | 21 |
Top |
Fusion breakpoint peptide structures of FGFR3-AMBRA1 |
![]() * The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA. |
File name | BPseq | Hgene | Tgene | Hchr | Hbp | Tchr | Tbp | AAlen |
1391 | DRVLTVTSTDRVFN | FGFR3 | AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 2376 |
Top |
Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of FGFR3-AMBRA1 |
![]() * We used Glide to predict the interaction between HLAs and neoantigens. |
HLA allele | PDB ID | File name | BPseq | Docking score | Glide score |
HLA-B14:02 | 3BVN | 1391 | DRVLTVTSTDRVFN | -7.15543 | -7.26883 |
HLA-B14:02 | 3BVN | 1391 | DRVLTVTSTDRVFN | -4.77435 | -5.80965 |
HLA-B52:01 | 3W39 | 1391 | DRVLTVTSTDRVFN | -6.80875 | -6.92215 |
HLA-B52:01 | 3W39 | 1391 | DRVLTVTSTDRVFN | -4.20386 | -5.23916 |
HLA-A11:01 | 4UQ2 | 1391 | DRVLTVTSTDRVFN | -7.5194 | -8.5547 |
HLA-A11:01 | 4UQ2 | 1391 | DRVLTVTSTDRVFN | -6.9601 | -7.0735 |
HLA-A24:02 | 5HGA | 1391 | DRVLTVTSTDRVFN | -7.52403 | -7.63743 |
HLA-A24:02 | 5HGA | 1391 | DRVLTVTSTDRVFN | -5.82433 | -6.85963 |
HLA-B27:05 | 6PYJ | 1391 | DRVLTVTSTDRVFN | -3.28285 | -4.31815 |
HLA-B44:05 | 3DX8 | 1391 | DRVLTVTSTDRVFN | -5.91172 | -6.94702 |
HLA-B44:05 | 3DX8 | 1391 | DRVLTVTSTDRVFN | -4.24346 | -4.35686 |
Top |
Vaccine Design for the FusionNeoAntigens of FGFR3-AMBRA1 |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide sequence | FusionNeoAntigen RNA sequence |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 10 | 19 | TVTSTDRVF | TCCACCGACAGAGTTTTCAACGTCCTT |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 12 | 21 | TSTDRVFNV | GACAGAGTTTTCAACGTCCTTTATCCC |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 7 | 17 | RVLTVTSTDR | ACCGTGACGTCCACCGACAGAGTTTTCAAC |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide | FusionNEoAntigen RNA sequence |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 5 | 20 | LDRVLTVTSTDRVFN | GTCCTTACCGTGACGTCCACCGACAGAGTTTTCAACGTCCTTTAT |
FGFR3-AMBRA1 | chr4 | 1808661 | chr11 | 46439602 | 6 | 21 | DRVLTVTSTDRVFNV | CTTACCGTGACGTCCACCGACAGAGTTTTCAACGTCCTTTATCCC |
Top |
Information of the samples that have these potential fusion neoantigens of FGFR3-AMBRA1 |
![]() |
Cancer type | Fusion gene | Hchr | Hbp | Henst | Tchr | Tbp | Tenst | Sample |
GBM | FGFR3-AMBRA1 | chr4 | 1808661 | ENST00000260795 | chr11 | 46439602 | ENST00000298834 | TCGA-19-A6J4-01A |
Top |
Potential target of CAR-T therapy development for FGFR3-AMBRA1 |
![]() |
![]() * Minus value of BPloci means that the break point is located before the CDS. |
- In-frame and retained 'Transmembrane'. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FGFR3 | chr4:1808661 | chr11:46439602 | ENST00000260795 | + | 16 | 17 | 376_396 | 758 | 807.0 | Transmembrane | Helical |
Hgene | FGFR3 | chr4:1808661 | chr11:46439602 | ENST00000340107 | + | 17 | 18 | 376_396 | 760 | 809.0 | Transmembrane | Helical |
Hgene | FGFR3 | chr4:1808661 | chr11:46439602 | ENST00000352904 | + | 14 | 15 | 376_396 | 646 | 695.0 | Transmembrane | Helical |
Hgene | FGFR3 | chr4:1808661 | chr11:46439602 | ENST00000412135 | + | 15 | 16 | 376_396 | 646 | 695.0 | Transmembrane | Helical |
Hgene | FGFR3 | chr4:1808661 | chr11:46439602 | ENST00000440486 | + | 17 | 18 | 376_396 | 758 | 807.0 | Transmembrane | Helical |
![]() * We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image. |
Hgene | Hchr | Hbp | Henst | Tgene | Tchr | Tbp | Tenst | DeepLoc result |
Top |
Related Drugs to FGFR3-AMBRA1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to FGFR3-AMBRA1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FGFR3 | C0001080 | Achondroplasia | 13 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR3 | C0410529 | Hypochondroplasia (disorder) | 10 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR3 | C1864436 | Muenke Syndrome | 9 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR3 | C1868678 | THANATOPHORIC DYSPLASIA, TYPE I (disorder) | 9 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | FGFR3 | C2677099 | CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS (disorder) | 7 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | FGFR3 | C0005684 | Malignant neoplasm of urinary bladder | 6 | CGI;CTD_human;UNIPROT |
Hgene | FGFR3 | C0005695 | Bladder Neoplasm | 4 | CGI;CTD_human |
Hgene | FGFR3 | C1300257 | Thanatophoric dysplasia, type 2 | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | FGFR3 | C1864852 | CATSHL syndrome | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR3 | C2674173 | Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR3 | C0265269 | Lacrimoauriculodentodigital syndrome | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR3 | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
Hgene | FGFR3 | C0008924 | Cleft upper lip | 1 | CTD_human |
Hgene | FGFR3 | C0008925 | Cleft Palate | 1 | CTD_human |
Hgene | FGFR3 | C0014544 | Epilepsy | 1 | GENOMICS_ENGLAND |
Hgene | FGFR3 | C0014547 | Epilepsies, Partial | 1 | GENOMICS_ENGLAND |
Hgene | FGFR3 | C0022603 | Seborrheic keratosis | 1 | UNIPROT |
Hgene | FGFR3 | C0026764 | Multiple Myeloma | 1 | CGI;CTD_human |
Hgene | FGFR3 | C0036631 | Seminoma | 1 | CTD_human |
Hgene | FGFR3 | C0039743 | Thanatophoric Dysplasia | 1 | CTD_human |
Hgene | FGFR3 | C0152423 | Congenital small ears | 1 | GENOMICS_ENGLAND |
Hgene | FGFR3 | C0206726 | gliosarcoma | 1 | ORPHANET |
Hgene | FGFR3 | C0221356 | Brachycephaly | 1 | ORPHANET |
Hgene | FGFR3 | C0265529 | Plagiocephaly | 1 | ORPHANET |
Hgene | FGFR3 | C0334082 | NEVUS, EPIDERMAL (disorder) | 1 | CTD_human;UNIPROT |
Hgene | FGFR3 | C0334588 | Giant Cell Glioblastoma | 1 | ORPHANET |
Hgene | FGFR3 | C0406803 | Syringocystadenoma Papilliferum | 1 | GENOMICS_ENGLAND |
Hgene | FGFR3 | C1336708 | Testicular Germ Cell Tumor | 1 | CTD_human;UNIPROT |
Hgene | FGFR3 | C1837218 | Cleft palate, isolated | 1 | CTD_human |
Hgene | FGFR3 | C4048328 | cervical cancer | 1 | CTD_human;UNIPROT |